Navigation Links
FDA Accepts Sanofi Pasteur File Submission for Novel Influenza Vaccine Delivered by Intradermal Microinjection
Date:9/13/2010

SWIFTWATER, Pa., Sept. 13 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced today that it has filed a Supplemental Biologics License Application (sBLA) with the U.S. Food and Drug Administration (FDA) for Fluzone® Intradermal (Influenza Virus Vaccine).  The file has been accepted by the FDA and an action date is anticipated in the first half of 2011.

"Upon FDA licensure, this new formulation of Sanofi Pasteur's Fluzone vaccine will be the first vaccine available in the U.S. using a novel microinjection system for intradermal delivery of vaccine," said Wayne Pisano, President and Chief Executive Officer, Sanofi Pasteur.  "We believe that Fluzone Intradermal Vaccine could be an important tool in increasing adult immunization rates due to its ease of use for health-care providers and the high-level of interest expressed by patients for this immunization option."

Typically, adult vaccines are administered into the muscle (referred to as intramuscular or IM injection) utilizing a needle 1 inch to 1.5 inches in length (approximately 25 mm to 40 mm) depending on body mass.  Vaccination via the intradermal (ID) route involves introduction of the vaccine into the dermal layer of the skin with an ultra-thin needle of only 1.5 mm in length, or less than one-tenth the length of the standard needles used for the traditional IM route of administration.  The injection volume is only 0.1 mL, or one-fifth the amount injected when vaccine is administered using standard IM administration.

In addition to providing a less invasive option that may be preferred by patients, ID vaccination is believed to stimulate an antibody response by having direct access to the immune system due to the high concentration of specialized immune cells in the dermal layer of the skin. &
'/>"/>

SOURCE Sanofi Pasteur
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. FDA Accepts Sanofi Pasteurs Application to Expand Indication of Menactra® Vaccine to Infants and Toddlers
2. Talecris Biotherapeutics CEO Accepts 2010 Ernst & Young Entrepreneur Of The Year Award on Behalf of Employees and Patients
3. FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review
4. FDA Accepts sNDA for Alternative Dosing Regimen for Dacogen(R) (decitabine for injection) to Treat Patients with Myelodysplastic Syndromes (MDS)
5. FDA Accepts Arno Therapeutics IND for AR-12 a PDK1 Inhibitor That Blocks the PI3K/Akt Pathway
6. Food and Drug Administration Accepts Isolagens Biologics License Application for Full Review
7. FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)
8. European Regulatory Agency Accepts Cell Therapeutics, Inc.s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review
9. FDA Accepts Investigational New Drug Application for ARI-2243 and a First in Man Clinical Trial Set to Begin During the First Half of 2008
10. FDA Accepts Wyeths Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia
11. Sanofi-aventis Announces Non-Binding Offer to Acquire Genzyme
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... , May 27, 2015 /PRNewswire/ ... MXIM ) makes it easy to ... to monitor or control unsanitary reuse ... gamma-radiation-resistant, nonvolatile (NV) 1-Wire® memory. ... http://www.maximintegrated.com/en/products/digital/memory-products/DS28E80.html , Maxim,s ...
(Date:5/27/2015)... May 27, 2015 In a new ... Canadian International Pharmacy Association (CIPA) found continued ... licensed Canadian pharmacies. Approximately 64% of respondents purchase some ... a non-U.S. pharmacy due to costs of filling ... under their insurance plan.   Many news ...
(Date:5/27/2015)... May 27, 2015  Genomic Health, Inc. (Nasdaq: GHDX ... Officer and Chief Financial Officer, will present at the Jefferies ... on Monday, June 1 at 8:30 a.m. Eastern ... archived webcast of the presentation, go to the  Investor Relations ... Please connect to the web site at least 15 minutes ...
Breaking Medicine Technology:Gamma-Radiation-Resistant Memory Provides Calibration and Protects from Unsanitary Reuse in Medical Disposables 2Gamma-Radiation-Resistant Memory Provides Calibration and Protects from Unsanitary Reuse in Medical Disposables 3Canadian International Pharmacy Association (CIPA) Survey of Americans Finds 64% Purchase Medications from Canada Due to Affordability 2Canadian International Pharmacy Association (CIPA) Survey of Americans Finds 64% Purchase Medications from Canada Due to Affordability 3Genomic Health to Present at the Jefferies 2015 Global Healthcare Conference 2Genomic Health to Present at the Jefferies 2015 Global Healthcare Conference 3
... , Feb. 17 /PRNewswire / -- SI-BONE, Inc. ( ... use of a minimally invasive surgical device to treat sacroiliac (SI) ... joined the Company,s Medical Advisory Board.  Drs. Frank M. Phillips ... join Drs. Steven R. Garfin (chair), Mark ...
... SAN DIEGO , Feb. 17 Hollis-Eden Pharmaceuticals, ... its name to Harbor BioSciences, Inc. and that its ticker symbol ... 2010 . The company also received a new CUSIP number (41150V ... begin 2010 with a targeted business strategy focused on attaining proof-of-concept ...
Cached Medicine Technology:Frank Phillips, Paul Anderson and Federico Girardi Join SI-BONE's Medical Advisory Board 2Frank Phillips, Paul Anderson and Federico Girardi Join SI-BONE's Medical Advisory Board 3Frank Phillips, Paul Anderson and Federico Girardi Join SI-BONE's Medical Advisory Board 4Hollis-Eden Announces Name Change to Harbor BioSciences, Inc. and Ticker Symbol Change to 'HRBR' 2Hollis-Eden Announces Name Change to Harbor BioSciences, Inc. and Ticker Symbol Change to 'HRBR' 3
(Date:5/27/2015)... Rolling Meadows, IL (PRWEB) May 27, 2015 ... the release of its SonarMD Platform, a ... engaging, monitoring and managing patients with chronic ... Lawrence Kosinski, MD, MBA, the application allows ... between visits through the ongoing use of ...
(Date:5/27/2015)... SmarterSkin, http://www.smarterskindermatology.com , is taking skin ... that makes it easier for patients to find skin care ... Dr. Sejal Shah is a cosmetic dermatologist based in New ... the test. This revolutionary DNA test uses 16 genetic markers ... , 1. Firmness and elasticity , 2. Glycation ...
(Date:5/27/2015)... CRN International, the radio marketing and promotions ... Financial Officer. , Prinner most recently was Principal of ... financial/operational executive positions at telecom and technology services companies ... and SNET. His accounting and consulting career began ... will be able to tap into his experience of ...
(Date:5/27/2015)... May 27, 2015 Representatives from Classified ... year’s conference of the American Immigration Lawyers Association (AILA). ... National Resort. MCA’s booth is #404. , The annual ... Immigration Law.” MCAads.com, a regular AILA conference attendee, describes ... they welcome current clients to their booth and make ...
(Date:5/27/2015)... 27, 2015 National Healthcare ... award winning web development and interactive marketing ... the launch of its newly redesigned, custom ... National Healthcare Providers, is a physician owned ... the areas of Radiology, Anesthesiology, Emergency and ...
Breaking Medicine News(10 mins):Health News:SonarMD™, LLC, Launches Game-Changing, IBD Population Health Management Platform 2Health News:SmarterSkin Dermatology is Now Offering Skin DNA Analysis 2Health News:CRN International Names New Chief Financial Officer 2Health News:PERM Specialists from MCAads.com Will Attend the 2015 Conference on Immigration Law Set for June 17-20 in the DC Metro Area 2Health News:PERM Specialists from MCAads.com Will Attend the 2015 Conference on Immigration Law Set for June 17-20 in the DC Metro Area 3Health News:National Healthcare Providers Showcases Expanded Business Model with Launch of New Website 2Health News:National Healthcare Providers Showcases Expanded Business Model with Launch of New Website 3
... reason not to eat pate de foie gras is discussed ... States, Washington DC in a forthcoming issue of the ... , Harmful proteins fragments known as amyloid fibrils associated with ... cells in Type II diabetes can be present in the ...
... Scientists at the University of Liverpool will launch a ... such as HIV and tuberculosis. , The Centre, which ... the Health Protection Agency, is one of 12 in ... for Health Research (NIHR) as part of the Government,s ...
... CHARLOTTE, N.C., Feb. 10 USHIFU, a worldwide ... invasive high intensity focused,ultrasound technologies, is pleased to ... consulting position of Chief Medical Officer. Dr.,Schoenberg is ... Urologic,Oncology who has authored more than 100 peer-reviewed ...
... Feb. 10 Erdman, A Cogdell Spencer,Company is ... Erdman,Place, has earned the U.S. Environmental Protection Agency,s ... energy efficiency,and environmental protection. America,s commercial buildings and ... of similar facilities for energy,efficiency may qualify for ...
... SAN DIEGO, Feb. 10 NuVasive, Inc. (Nasdaq: ... developing products for minimally disruptive surgical treatments for the ... & Chief Financial Officer, is scheduled to present at ... The Ritz-Carlton Hotel in Laguna Niguel, California on Tuesday, ...
... one-of-a-kind claims processing, business intelligence, and portal ... in the 21st-century healthcare marketplaceBURLINGTON, Mass., Feb. ... modern, enterprise-class software platform for healthcare payors, ... selected the HealthRules product suite as their ...
Cached Medicine News:Health News:Give the foie gras a miss 2Health News:Biomedical research center opens in Liverpool 2Health News:USHIFU Appoints Mark Schoenberg, M.D. Chief Medical Officer 2Health News:Erdman, A Cogdell Spencer Company Earns the ENERGY STAR(R) for Superior Energy 2Health News:Erdman, A Cogdell Spencer Company Earns the ENERGY STAR(R) for Superior Energy 3Health News:Erdman, A Cogdell Spencer Company Earns the ENERGY STAR(R) for Superior Energy 4Health News:NuVasive to Present at ROTH 21st Annual OC Growth Stock Conference 2Health News:NuVasive to Present at ROTH 21st Annual OC Growth Stock Conference 3Health News:Mississippi Administrative Services Chooses the HealthRules(R) Product Suite from HealthEdge(R) to Address Next-Generation Business Needs 2
... The SYNCHRON CX9 ALX system is ... time-consuming manual processes by as much as ... lower your total costs. Featuring the AccuSense® ... and an expanded test menu, the CX9 ...
... for the mid- to high-volume lab, the ... can reduce time-consuming manual tasks by as ... performs random access, STAT, HCFA panels and ... including Stat chemistries, General chemistries, TDMs, DATs, ...
... It takes powerful technology to ... safety, and still lower costs. ... LX20 PRO, offering features that ... any other chemistry analyzer, including ...
... This user-friendly instrument is ... Protein analyzer for the ... is a well established ... results for a wide ...
Medicine Products: